Isogenica-Phenotypeca SMART Grant Collaboration Isogenica-Phenotypeca collaboration spear-headed by SMART Grant award Read the Press Release Isogenica are collaborating with Phenotypeca, a biofoundry business who create and own yeast synthetic biology solutions...
Isogenica-PipeBio Collaboration Press Release Isogenica announce deployment of the PipeBio Bioinformatic Cloud Read the Press Release Isogenica today announce that they are deploying PipeBio’s bioinformatic cloud to accelerate their drug...
Isogenica announced today that Dr William (Bill) Eldridge has been promoted to Chief Scientific Officer. Since joining Isogenica as Senior Director of Antibody Alliances in January 2020, Dr Eldridge has played a leading role in delivering Isogenica’s multi-target...
Isogenica multi-year multi-target collaboration with Aro Biotherapeutics extended Isogenica-Aro collaboration goes from strength to strength Read The Press Release Isogenica today announced the collaboration and license agreement signed with Aro Biotherapeutics in...
Isogenica announces multimillion-pound agreement with recently nasdaq listed BioNTech SE Isogenica multi-target, multi-year collaboration and license agreement with BioNTech SE Isogenica has entered into a multi-target, multi-year partnership with BioNTech. The...
Isogenica appoints Dr Bjӧrn Cochlovius to the Board of Directors Dr Cochlovius joins Isogenica as a non-executive director replacing Dr Gӧran Forsberg, who stepped down from the Board on October 11, 2019. Dr Forsberg has served as a non-executive director since...
